Search Results for "Breast Pap Test Trial"
Original Source: NeoMatrix, LLC
Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versu...
Matching Channels
Breast cancer in the UK is diagnosed in nearly 46,000 people each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...
The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...
Matching News
A SIMPLE blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers, as Breast Cancer Awareness Month gets underw...
Oncology Spotlight: Galena’s NeuVax Phase III Breast Cancer Trial
Portland, Oregon-based Galena Biopharmaceuticals has begun recruiting breast cancer patients for its Phase III PRESENT (Prevention of Recurrence in Early-Stage Node-Positive Breast Cancer with Low to...
Oncology Spotlight: Galena’s NeuVax Phase 3 Breast Cancer Trial
Portland, Oregon-based Galena Biopharmaceuticals has begun recruiting breast cancer patients for its Phase III PRESENT (Prevention of Recurrence in Early-Stage Node-Positive Breast Cancer with Low to...
A simple blood test could be used to detect breast cancer
A simple blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers today, as Breast Cancer Awareness Month gets...
CanDiag Inc. spun out of the University of North Carolina at Charlotte to develop an antibody-based blood test for detecting early-stage breast cancer. The start-up will first use the technology to de...
New clinical study to determine whether DNA in blood could show early signs of breast cancer
A SIMPLE blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers today, as Breast Cancer Awareness Month gets...
NanoString breast cancer test wins CE mark
NanoString Technologies has gained rights to market its PAM50-based gene expression test for breast cancer in the European Union and other countries recognizing the CE mark.
Embryo test for breast cancer is feasible
A lab test to screen embryos for inherited risk of breast or ovarian cancer is "feasible" but controversy surrounding this method is unlikely to be stilled, a fertility conference heard on M...
Matching PubMed Articles
Endocrine therapy for breast cancer may affect cognition. The purpose of this study was to examine whether cognitive function improves after cessation of adjuvant endocrine therapy. Change in cognitiv...
The purpose of this study was to determine the ipsilateral breast tumor recurrence (IBTR) in ductal carcinoma in situ (DCIS) patients treated in the American Society of Breast Surgeons MammoSite Breas...
Breast MRI is often used for surveillance of breast cancer (BC) survivors despite the lack of evidence in this population. We surveyed younger BC survivors to evaluate their willingness to participate...
Trial watch: ERBB2 dimerization inhibitor meets end point in breast cancer trial.
Observational studies suggest that host factors are associated with breast cancer risk. The influence of obesity, vitamin-D status, insulin resistance, inflammation, and elevated adipocytokines in wom...
